Literature DB >> 12539260

Structural models for dimerization of G-protein coupled receptors: the opioid receptor homodimers.

Marta Filizola1, Harel Weinstein.   

Abstract

Among the most exciting functional features of G-protein coupled receptors (GPCRs) that are coming into focus lately are those relating to the role and structural characteristics of their oligomerization (mostly homo- and heterodimers). The structural underpinnings of these novel functional insights are still not clear, as current experimental techniques have not yet succeeded in identifying the dimerization interfaces between GPCR monomers. Two computational approaches have recently been designed in our lab to provide reasonable three-dimensional (3D) molecular models of the transmembrane (TM) regions of GPCR dimers based on a combination of the structural information of receptor monomers and analyses of correlated mutations in receptor families. The modeling of GPCR heterodimers has been described recently. We present here a related approach for modeling of GPCR homodimers that identifies the interfaces in the most likely configurations of the complexes. The approach is illustrated for the three cloned opioid receptor subtypes (OPRD, OPRM, and OPRK). Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12539260     DOI: 10.1002/bip.10311

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  19 in total

1.  Structural basis for μ-opioid receptor binding and activation.

Authors:  Adrian W R Serohijos; Shuangye Yin; Feng Ding; Josee Gauthier; Dustin G Gibson; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Structure       Date:  2011-11-09       Impact factor: 5.006

2.  Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation.

Authors:  Wen Guo; Lei Shi; Marta Filizola; Harel Weinstein; Jonathan A Javitch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

3.  Detection of pairwise residue proximity by covariation analysis for 3D-structure prediction of G-protein-coupled receptors.

Authors:  Wataru Nemoto; Takashi Imai; Takuya Takahashi; Takeshi Kikuchi; Norihisa Fujita
Journal:  Protein J       Date:  2004-08       Impact factor: 2.371

Review 4.  Co-evolution analysis on endocrine research: a methodological approach.

Authors:  Tonghai Dou; Shuai Chen; Chaoneng Ji; Yi Xie; Yumin Mao
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

Review 5.  Entropy and oligomerization in GPCRs.

Authors:  Rajkumar P Thummer; Matthew P Campbell; Mark K Dean; Marie J Frusher; Paul D Scott; Christopher A Reynolds
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 6.  Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers.

Authors:  Patricia H Reggio
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

Review 7.  Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors.

Authors:  Harel Weinstein
Journal:  AAPS J       Date:  2006-01-06       Impact factor: 4.009

8.  Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.

Authors:  Kaleeckal G Harikumar; Maoqing Dong; Zhijie Cheng; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

9.  A G Protein-Coupled Receptor Dimerization Interface in Human Cone Opsins.

Authors:  Beata Jastrzebska; William D Comar; Megan J Kaliszewski; Kevin C Skinner; Morgan H Torcasio; Anthony S Esway; Hui Jin; Krzysztof Palczewski; Adam W Smith
Journal:  Biochemistry       Date:  2016-11-29       Impact factor: 3.162

Review 10.  Opioid-receptor-heteromer-specific trafficking and pharmacology.

Authors:  Richard M van Rijn; Jennifer L Whistler; Maria Waldhoer
Journal:  Curr Opin Pharmacol       Date:  2009-10-19       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.